“The Paceline fund offers us an opportunity to utilize highly sophisticated, novel technology to test our hypothesis and obtain insightful preliminary data,” says Zoya Kurago, PhD.
“It is a great opportunity because we have a lot of great colleagues and great support in terms of core facilities and staff,” says Ahmed Chadli, PhD.
“This funding is essential for patients whose insurance does not cover this,” said Amanda Reiter, an outpatient oncology dietitian at the GCC.
The grant awarded for Chadli’s research focuses on a specific protein, UNC45A, that can be used as a promising novel immunotherapeutic target in treating triple-negative breast...